Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of KNP2002 ointment in patients with common warts
jRCT2031230115Phase 2Active, not recruiting
- Sponsor
- KinoPharma, Inc.
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of KNP-2002 in common wart (4 arms), sponsored by KinoPharma, Inc. Primary endpoints: Adverse events and Change in wart area from baseline at endpoint. Started Jun 2023; status: active, not recruiting.
02
Drugs
KNP-2002
03
Conditions
common wart
Beyond the preview
Go deeper on jRCT2031230115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230115.